These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Crystal structure and biochemical characterization of O-acetylhomoserine acetyltransferase from Mycobacterium smegmatis ATCC 19420. Sagong HY; Hong J; Kim KJ Biochem Biophys Res Commun; 2019 Sep; 517(3):399-406. PubMed ID: 31378370 [TBL] [Abstract][Full Text] [Related]
7. 2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1. Neres J; Hartkoorn RC; Chiarelli LR; Gadupudi R; Pasca MR; Mori G; Venturelli A; Savina S; Makarov V; Kolly GS; Molteni E; Binda C; Dhar N; Ferrari S; Brodin P; Delorme V; Landry V; de Jesus Lopes Ribeiro AL; Farina D; Saxena P; Pojer F; Carta A; Luciani R; Porta A; Zanoni G; De Rossi E; Costi MP; Riccardi G; Cole ST ACS Chem Biol; 2015 Mar; 10(3):705-14. PubMed ID: 25427196 [TBL] [Abstract][Full Text] [Related]
8. Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex. Sammartino JC; Morici M; Stelitano G; Degiacomi G; Riccardi G; Chiarelli LR Biochem Biophys Res Commun; 2022 Jun; 607():49-53. PubMed ID: 35366543 [TBL] [Abstract][Full Text] [Related]
9. Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis. Ribeiro AL; Degiacomi G; Ewann F; Buroni S; Incandela ML; Chiarelli LR; Mori G; Kim J; Contreras-Dominguez M; Park YS; Han SJ; Brodin P; Valentini G; Rizzi M; Riccardi G; Pasca MR PLoS One; 2011; 6(11):e26675. PubMed ID: 22069462 [TBL] [Abstract][Full Text] [Related]
10. Antituberculars which target decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1: state of art. Buroni S; Pasca MR; de Jesus Lopes Ribeiro AL; Degiacomi G; Molteni E; Riccardi G Appl Microbiol Biotechnol; 2012 May; 94(4):907-16. PubMed ID: 22526781 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship mediated molecular insights of DprE1 inhibitors: A Comprehensive Review. Dash S; Rathi E; Kumar A; Chawla K; Joseph A; Kini SG J Biomol Struct Dyn; 2024 Aug; 42(12):6472-6522. PubMed ID: 37395797 [TBL] [Abstract][Full Text] [Related]
12. Functional identification of MSMEG_6402 protein from Mycobacterium smegmatis in decaprenylphosphoryl-D-arabinose biosynthesis. Jiang T; Cai L; Zhao X; He L; Ma Y; Zang S; Zhang C; Li X; Xin Y Microb Pathog; 2014 Nov; 76():44-50. PubMed ID: 25223716 [TBL] [Abstract][Full Text] [Related]
13. Binding of NADP Blaise M; Van Wyk N; Banères-Roquet F; Guérardel Y; Kremer L Biochem J; 2017 Mar; 474(6):907-921. PubMed ID: 28126742 [TBL] [Abstract][Full Text] [Related]
14. The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Ezquerra-Aznárez JM; Degiacomi G; Gašparovič H; Stelitano G; Sammartino JC; Korduláková J; Governa P; Manetti F; Pasca MR; Chiarelli LR; Ramón-García S Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054958 [TBL] [Abstract][Full Text] [Related]
15. Decaprenylphosphoryl-β-D-ribose 2'-epimerase from Mycobacterium tuberculosis is a magic drug target. Manina G; Pasca MR; Buroni S; De Rossi E; Riccardi G Curr Med Chem; 2010; 17(27):3099-108. PubMed ID: 20629622 [TBL] [Abstract][Full Text] [Related]
16. Virtual Screening of Small Molecular Inhibitors against DprE1. Zhang G; Guo S; Cui H; Qi J Molecules; 2018 Feb; 23(3):. PubMed ID: 29495447 [TBL] [Abstract][Full Text] [Related]
17. Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies. Bhutani I; Loharch S; Gupta P; Madathil R; Parkesh R PLoS One; 2015; 10(3):e0119771. PubMed ID: 25789990 [TBL] [Abstract][Full Text] [Related]
18. Genomic organization and in vivo characterization of proteolytic activity of FtsH of Mycobacterium smegmatis SN2. Anilkumar G; Srinivasan R; Ajitkumar P Microbiology (Reading); 2004 Aug; 150(Pt 8):2629-2639. PubMed ID: 15289559 [TBL] [Abstract][Full Text] [Related]
19. Structural and kinetic studies on adenylosuccinate lyase from Mycobacterium smegmatis and Mycobacterium tuberculosis provide new insights on the catalytic residues of the enzyme. Banerjee S; Agrawal MJ; Mishra D; Sharan S; Balaram H; Savithri HS; Murthy MR FEBS J; 2014 Mar; 281(6):1642-58. PubMed ID: 24479855 [TBL] [Abstract][Full Text] [Related]
20. Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance. Manina G; Bellinzoni M; Pasca MR; Neres J; Milano A; Ribeiro AL; Buroni S; Skovierová H; Dianišková P; Mikušová K; Marák J; Makarov V; Giganti D; Haouz A; Lucarelli AP; Degiacomi G; Piazza A; Chiarelli LR; De Rossi E; Salina E; Cole ST; Alzari PM; Riccardi G Mol Microbiol; 2010 Sep; 77(5):1172-85. PubMed ID: 20624223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]